AI Assistant
Blog
Pricing
Log In
Sign Up
Potential therapy for Ph1-ALL and CML tumors unresponsive to imatinib and/or dasatinib
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
